Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/29303| Title: | Antiangiogenic and antiproliferative assessment of cyanobacteria |
| Authors: | Kyadari, Mahender Fatma, Tasneem Velpandian, Thirumurthy Malliga, P Bharat, Naveen Bano, Fareha |
| Keywords: | Algae;Angiogenesis;Chorio Allontoic Membrane;VEGF |
| Issue Date: | Aug-2014 |
| Publisher: | NISCAIR-CSIR, India |
| Abstract: | Biologically active compounds with different modes of action, such as antiproliferative, antioxidant, antimicrotubule, have been isolated from algae and cyanobacteria. The present study was designed to evaluate antiangiogenic and antiproliferative potential of dichloromethane and methanol (2:1) extracts of different cyanobacteria. Further fingerprinting of the activity possessing extracts were carried out using ESI-LC-MS/MS. Extracts (25, 50 and 100 µg) were screened in the vascular endothelial growth factor (VEGF) induced angiogenesis in inovo chick chorioallontoic membrane assay (CAM) at various concentrations using thalidomide and normal saline as positive and untreated control groups respectively. The extracts were also evaluated for their antiproliferative activity by MTT assay using HeLa cancer cell line. The results obtained from the various algal extracts did not show any significant antiangiogenic activity as compared to VEGF control. Oscillatoria sp. and Lyngbya officinalis exhibited significant anti-proliferative activity at IC50 values of 220 and 260 µg/mL respectively. ESI-LC-MS/MS of L. officinalis showed the presence of lyngbyatoxin-A and that of Oscillatoria sp. reveals the presence of malyngamide-J suggesting the possibility of antiproliferative activity. |
| Page(s): | 835-842 |
| ISSN: | 0975-1009 (Online); 0019-5189 (Print) |
| Appears in Collections: | IJEB Vol.52(08) [August 2014] |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJEB 52(8) 835-842.pdf | 565.31 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.